Boga, A. Et Al. 2017. Evaluating the teratogenicity of the selective beta 3-adrenoceptor agonist, CL 316.243 hydrate by employing FETAX (frog embryo teratogenesis assay). DRUG AND CHEMICAL TOXICOLOGY , vol.40, no.1 , 7-12.

Boga, A., SERTDEMİR, Y., & DOĞAN, A., (2017). Evaluating the teratogenicity of the selective beta 3-adrenoceptor agonist, CL 316.243 hydrate by employing FETAX (frog embryo teratogenesis assay). DRUG AND CHEMICAL TOXICOLOGY , vol.40, no.1, 7-12.

Boga, AYPER, YAŞAR SERTDEMİR, And AYŞE DOĞAN. "Evaluating the teratogenicity of the selective beta 3-adrenoceptor agonist, CL 316.243 hydrate by employing FETAX (frog embryo teratogenesis assay)," DRUG AND CHEMICAL TOXICOLOGY , vol.40, no.1, 7-12, 2017

Boga, AYPER B. Et Al. "Evaluating the teratogenicity of the selective beta 3-adrenoceptor agonist, CL 316.243 hydrate by employing FETAX (frog embryo teratogenesis assay)." DRUG AND CHEMICAL TOXICOLOGY , vol.40, no.1, pp.7-12, 2017

Boga, A. SERTDEMİR, Y. And DOĞAN, A. (2017) . "Evaluating the teratogenicity of the selective beta 3-adrenoceptor agonist, CL 316.243 hydrate by employing FETAX (frog embryo teratogenesis assay)." DRUG AND CHEMICAL TOXICOLOGY , vol.40, no.1, pp.7-12.

@article{article, author={AYPER BOĞA PEKMEZEKMEK Et Al. }, title={Evaluating the teratogenicity of the selective beta 3-adrenoceptor agonist, CL 316.243 hydrate by employing FETAX (frog embryo teratogenesis assay)}, journal={DRUG AND CHEMICAL TOXICOLOGY}, year=2017, pages={7-12} }